Dividends Calendar Earnings Calendar

SABS | SAB Biotherapeutics

  • Industry: Biotechnology

Quick infos

  • Headquarters:   Sioux Falls, South Dakota, United States

Trade prices

  • Volume:
  • Market Cap: 59.75M
  • Prev closed:
  • Open: 5.2
  • High: 5.3
  • Low: 4.77
  • 52 week low: 4.64
  • 52 week high: 12.9
  • Dividends:No Dividends

Next ER: May 18, 2023  After Market Closes

Top Stories (SABS)

    Company Profile

    SAB Biotherapeutics is a clinical-stage biopharmaceutical company leveraging its novel DiversitAb™ platform to produce a new class of specifically targeted, high-potency, fully-human polyclonal antibodies without the need for human donors. By harnessing the native human antibody immune response, SAB's platform enables a scalable and reliable production of these highly-efficacious polyclonal therapies with the potential to address the emergence, mutation, and diversity of modern health challenges including COVID-19, seasonal influenza, Type 1 diabetes, and cancers. The Company's lead product candidates include SAB-185, a fully-human polyclonal antibody therapeutic for the treatment of COVID-19 advancing as part of the NIH's ACTIV-2 protocol, and SAB-176, a multivalent, broadly neutralizing fully-human polyclonal antibody therapeutic candidate designed to bind to Type A and B viruses. Additional pre-clinical product candidates are in development for autoimmune diseases, including SAB-142 for Type 1 Diabetes and organ transplant induction/rejection, and SAB-181 for immune globulin (IgG) mediated diseases.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 9, 2023
    May 16, 2023-0.15 / -0.04600K / 8.2MBeat!
    March 31, 2023-0.17 / -0.08672.2M / 6.5MBeat!
    November 15, 2022-0.16 / -0.14333.59M / 3.59M
    August 10, 2022-0.11 / -0.136.35M / 6.38M
    view more

    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2014
    • Employees:143


    This company doesn't provide a dividend.

    Talk about SAB Biotherapeutics below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.

    Other ER on May 18, 2023 (Same day)

    baba wmt manu rost flo dxc ftch doyu qfin csiq ycbd nndm 

    Jump to (Finance sites)

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 

    Recommended Books

    Swing Trading For Dummies
    Buy on Amazon

    Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.

    Take advantage of price swings in strongly trending securities and pump up your portfolio!